Silverarc Capital Management »

Olema Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.0M 408k 12.35
2023-06-30 $3.5M 391k 9.03

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Olema Pharmaceuticals

BVF
Paradigm Biocapital Advisors
Logos Global Management
Vanguard Group
Cormorant Asset Management
Vivo Capital
Dimensional Fund Advisors
Henderson Group
First Light Asset Management
Victory Capital Management
Kingdon Capital Management
Perceptive Advisors
Citadel Advisors
Goldman Sachs Group
Marshall Wace

View all funds holding Olema Pharmaceuticals